Shareholder Alert: Monteverde & Associates PC Announces Investigation of Acasti Pharma, Inc.-ACST – QNT Press Release

[ad_1]

new York, July 3, 2021 /PRNewswire/ – Juan Monteverde, Founder and managing partner Monteverde & Associates PC, Was rated as a national securities company Top 50 In the 2018-2020 ISS Securities Class Action Service Report, headquartered in the Empire State Building, New York New York City,investigating Acasti Pharma, Inc. (“ACST” or “Company”) (ACST) In connection with the proposed merger of Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.

The focus of the investigation is whether Acasti Pharma, Inc. and its board of directors violated the securities laws and/or breached their fiduciary obligations to the company due to 1) failure to conduct fair procedures and 2) whether the valuation of the transaction was appropriate.

Click here for more information: http://monteverdelaw.com/case/acasti-pharma-inc. It is free, you do not need to bear any fees or obligations.